Like I said before, I bought a little bit more at .19, but only an amount I am willing to lose. 5 years ago, this company looked so promising. It really is sad to see how poorly it has been run considering its potential. Unless they have been lying to us, the technology can literally save countless lives. A competent leader would have a product in the market by now and would be generating revenue to fund further R&D and FDA approvals.
News 
Market Data 
Discover 
